140 related articles for article (PubMed ID: 29354123)
1. Congenital Cytomegalovirus Infection: Maternal-Child HLA-C, HLA-E, and HLA-G Affect Clinical Outcome.
Rovito R; Claas FHJ; Haasnoot GW; Roelen DL; Kroes ACM; Eikmans M; Vossen ACTM
Front Immunol; 2017; 8():1904. PubMed ID: 29354123
[TBL] [Abstract][Full Text] [Related]
2. Maternal and child human leukocyte antigens in congenital cytomegalovirus infection.
Rovito R; Claas FHJ; Haasnoot GW; Roelen DL; Kroes ACM; Vossen ACTM
J Reprod Immunol; 2018 Apr; 126():39-45. PubMed ID: 29477013
[TBL] [Abstract][Full Text] [Related]
3. Impact of congenital cytomegalovirus infection on transcriptomes from archived dried blood spots in relation to long-term clinical outcome.
Rovito R; Warnatz HJ; Kiełbasa SM; Mei H; Amstislavskiy V; Arens R; Yaspo ML; Lehrach H; Kroes ACM; Goeman JJ; Vossen ACTM
PLoS One; 2018; 13(7):e0200652. PubMed ID: 30024899
[TBL] [Abstract][Full Text] [Related]
4. T and B Cell Markers in Dried Blood Spots of Neonates with Congenital Cytomegalovirus Infection: B Cell Numbers at Birth Are Associated with Long-Term Outcomes.
Rovito R; Korndewal MJ; van Zelm MC; Ziagkos D; Wessels E; van der Burg M; Kroes AC; Langerak AW; Vossen AC
J Immunol; 2017 Jan; 198(1):102-109. PubMed ID: 27903736
[TBL] [Abstract][Full Text] [Related]
5. Neonatal screening parameters in infants with congenital Cytomegalovirus infection.
Rovito R; Korndewal MJ; Schielen PCJI; Kroes ACM; Vossen ACTM
Clin Chim Acta; 2017 Oct; 473():191-197. PubMed ID: 28847685
[TBL] [Abstract][Full Text] [Related]
6. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
Buxmann H; Stackelberg OM; Schlößer RL; Enders G; Gonser M; Meyer-Wittkopf M; Hamprecht K; Enders M
J Perinat Med; 2012 Mar; 40(4):439-46. PubMed ID: 22752777
[TBL] [Abstract][Full Text] [Related]
7. HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection.
Tarragó D; González I; González-Escribano MF
BMC Genomics; 2022 Jun; 23(1):455. PubMed ID: 35725386
[TBL] [Abstract][Full Text] [Related]
8. Killer-cell immunoglobulin-like receptors and cytomegalovirus reactivation during late pregnancy.
Alvarado-Hernández DL; Benítez-Sánchez A; Rodríguez-Cuevas JS; Rosales-Saavedra T; Guerra-Palomares SE; Comas-García A; Noyola DE; García-Sepúlveda CA
Int J Immunogenet; 2016 Aug; 43(4):189-99. PubMed ID: 27277336
[TBL] [Abstract][Full Text] [Related]
9. The potential role of HLA-G polymorphism in maternal tolerance to the developing fetus.
Agrawal S; Pandey MK
J Hematother Stem Cell Res; 2003 Dec; 12(6):749-56. PubMed ID: 14977483
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss.
Williams EJ; Kadambari S; Berrington JE; Luck S; Atkinson C; Walter S; Embleton ND; James P; Griffiths P; Davis A; Sharland M; Clark JE
Arch Dis Child Fetal Neonatal Ed; 2014 May; 99(3):F230-6. PubMed ID: 24596404
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.
Enders G; Bäder U; Lindemann L; Schalasta G; Daiminger A
Prenat Diagn; 2001 May; 21(5):362-77. PubMed ID: 11360277
[TBL] [Abstract][Full Text] [Related]
12. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.
Kenneson A; Cannon MJ
Rev Med Virol; 2007; 17(4):253-76. PubMed ID: 17579921
[TBL] [Abstract][Full Text] [Related]
13. Impact of HLA-G 14-bp polymorphism on acute rejection and cytomegalovirus infection in kidney transplant recipients from northwestern China.
Jin ZK; Xu CX; Tian PX; Xue WJ; Ding XM; Zheng J; Ding CG; Ge GQ; Mao TC; Lin Y
Transpl Immunol; 2012 Oct; 27(2-3):69-74. PubMed ID: 22750489
[TBL] [Abstract][Full Text] [Related]
14. Congenital Cytomegalovirus Infection: Child Development, Quality of Life and Impact on Daily Life.
Korndewal MJ; Oudesluys-Murphy AM; Kroes ACM; Vossen ACTM; de Melker HE
Pediatr Infect Dis J; 2017 Dec; 36(12):1141-1147. PubMed ID: 28650934
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
16. HLA Class I protein expression in the human placenta.
Blaschitz A; Hutter H; Dohr G
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
[TBL] [Abstract][Full Text] [Related]
17. Distribution of Cytomegalovirus Genotypes among Neonates Born to Infected Mothers in Islamabad, Pakistan.
Mujtaba G; Khurshid A; Sharif S; Alam MM; Aamir UB; Shaukat S; Angez M; Rana MS; Umair M; Shah AA; Zaidi SS
PLoS One; 2016; 11(7):e0156049. PubMed ID: 27367049
[TBL] [Abstract][Full Text] [Related]
18. Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure.
Alecsandru D; Garrido N; Vicario JL; Barrio A; Aparicio P; Requena A; García-Velasco JA
Hum Reprod; 2014 Dec; 29(12):2637-43. PubMed ID: 25316448
[TBL] [Abstract][Full Text] [Related]
19. Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection.
Rizzo R; Gabrielli L; Bortolotti D; Gentili V; Piccirilli G; Chiereghin A; Pavia C; Bolzani S; Guerra B; Simonazzi G; Cervi F; Capretti MG; Fainardi E; Luca DD; Landini MP; Lazzarotto T
J Immunol Res; 2016; 2016():3890306. PubMed ID: 27699182
[TBL] [Abstract][Full Text] [Related]
20. How Does the maternal immune system contribute to the development of pre-eclampsia?
Moffett A; Hiby SE
Placenta; 2007 Apr; 28 Suppl A():S51-6. PubMed ID: 17292469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
